data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzdoNTEydjM0MS4zMjZIMHoiLz48cGF0aCBmaWxsPSIjRkY5ODExIiBkPSJNMCA4NS4zMzdoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjNkRBNTQ0IiBkPSJNMCAzMTIuODg4aDUxMnYxMTMuNzc1SDB6Ii8+PGNpcmNsZSBmaWxsPSIjMDA1MkI0IiBjeD0iMjU2IiBjeT0iMjU2IiByPSI0My44OTYiLz48Y2lyY2xlIGZpbGw9IiNGRkYiIGN4PSIyNTYiIGN5PSIyNTYiIHI9IjI3LjQzNCIvPjxwYXRoIGZpbGw9IiMwMDUyQjQiIGQ9Ik0yNTYgMjIyLjE0Nmw4LjQ2NCAxOS4xOTUgMjAuODU1LTIuMjY4TDI3Mi45MjcgMjU2bDEyLjM5MiAxNi45MjctMjAuODU1LTIuMjY4TDI1NiAyODkuODU0bC04LjQ2NC0xOS4xOTUtMjAuODU1IDIuMjY4TDIzOS4wNzMgMjU2bC0xMi4zOTItMTYuOTI3IDIwLjg1NSAyLjI2OHoiLz48L3N2Zz4=

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

My Account

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Adial Pharmaceuticals Inc

(NASDAQ:ADIL)

$2.52

0[0.00%]

Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here

$4.07

1.5500[61.51%]

Open-	Close-
Vol / Avg.6.000 / 134.809K	Mkt Cap3.069M
Day Range- - -	52 Wk Range2.500 - 15.000

0

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)

Adial Pharmaceuticals Stock (NASDAQ: ADIL)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 23, 2023

Adial Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
Benzinga Newsdesk - Aug 23, 2023, 8:31AM

Monday, August 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 21, 2023, 8:32AM
Adial Pharmaceuticals Cash Position: As Of June 30, 2023, Cash And Cash Equivalents Were $1.2M Compared To $4M As Of December 31, 2022
Happy Mohamed - Aug 21, 2023, 8:32AM

Friday, August 18, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Aug 18, 2023, 5:32PM

Monday, August 14, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Aug 14, 2023, 1:48PM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, August 04, 2023

Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq's Minimum Bid Price Requirement And Reduce The Public Float
Happy Mohamed - Aug 4, 2023, 8:34AM

Tuesday, August 01, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 1, 2023, 1:31PM

Monday, July 31, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 31, 2023, 1:31PM

Tuesday, July 25, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jul 25, 2023, 5:32PM

Wednesday, July 12, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jul 12, 2023, 1:37PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jul 12, 2023, 12:53PM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 12, 2023, 8:19AM
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga Newsdesk - Jul 12, 2023, 5:59AM

Tuesday, July 11, 2023

Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
Lisa Levin - Jul 11, 2023, 2:59PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jul 11, 2023, 1:37PM
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jul 11, 2023, 1:26PM
Why Are Adial Pharmaceuticals Shares Soaring Today
Vandana Singh - Jul 11, 2023, 12:48PM
Crude Oil Rises 2%; ADC Therapeutics Shares Plummet
Lisa Levin - Jul 11, 2023, 12:07PM
Adial Pharmaceuticals shares are trading higher after the company provided business update following favorable comments from US, EU regulatory meetings.
Benzinga Newsdesk - Jul 11, 2023, 9:54AM
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin - Jul 11, 2023, 9:48AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jul 11, 2023, 9:12AM
Adial Provides Business Update Following Favorable Comments From US And EU Regulatory Meetings
Happy Mohamed - Jul 11, 2023, 8:43AM

Thursday, June 15, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 15, 2023, 9:07AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM

Wednesday, May 24, 2023

Adial Pharmaceuticals Said On May 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Charles Gross - May 24, 2023, 4:59PM

Friday, May 12, 2023

Adial Pharmaceuticals Reports Q1 2023 Financial Results And Provides Business Update; As Of March 31, 2023, Cash And Cash Equivalents Were $2.3M
Happy Mohamed - May 12, 2023, 8:34AM

Wednesday, May 10, 2023

Adial Pharmaceuticals Receives Notice Of Exercise From Adovate For The Acquisition Of Purnovate's Assets And Business
Happy Mohamed - May 10, 2023, 8:40AM

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - May 2, 2023, 9:06AM

Friday, April 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 21, 2023, 1:31PM

Thursday, March 30, 2023

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results And Provides Business Update; As Of December 31, 2022, Cash And Cash Equivalents Were $4M
Happy Mohamed - Mar 30, 2023, 4:34PM

Monday, March 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 27, 2023, 9:06AM
Adial Pharma shares are trading higher after the company announced a partnership to further develop its treatment for alcohol use disorder.
Benzinga Newsdesk - Mar 27, 2023, 8:27AM

Tuesday, March 21, 2023

Adial Pharmaceuticals Engages The Keswick Group To Advance Partnering Activities For The Clinical Development Of AD04 For Alcohol Use Disorder
Happy Mohamed - Mar 21, 2023, 9:05AM

Wednesday, March 08, 2023

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 8, 2023, 7:57AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
Vandana Singh - Mar 7, 2023, 11:51AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Mar 7, 2023, 8:06AM
Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 7, 2023, 7:57AM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Adial shares are trading higher after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
Benzinga Newsdesk - Mar 6, 2023, 4:57PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Mar 6, 2023, 4:31PM
Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04 For Treatment Of Alcohol Use Disorder
Michael Horton - Mar 6, 2023, 4:21PM

Friday, February 24, 2023

Adial Pharmaceuticals Prices 1,829,269 Share Registered Direct Offering At $0.75/Share
Bill Haddad - Feb 24, 2023, 7:09AM

Tuesday, February 21, 2023

Adial Pharmaceuticals Confirms Scheduling Of Meetings With FDA And European Regulatory Agencies To Advance Clinical Development Of AD04 For Alcohol Use Disorder
Bill Haddad - Feb 21, 2023, 9:01AM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Feb 6, 2023, 8:06AM

Thursday, February 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Feb 2, 2023, 8:06AM

Wednesday, February 01, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 1, 2023, 4:30PM
Adial Pharmaceuticals Enters Into Option Agreement For Sale Of Purnovate Assets To Adenomed; Potential Development/Commercial Milestone Payments Of Up To $83M On First Three Compounds Plus Equity Stake And Ongoing Royalties
Happy Mohamed - Feb 1, 2023, 9:10AM

Monday, January 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Jan 23, 2023, 8:06AM

1
2
3
4
5
6
7
Next
17

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2023 Benzinga | All Rights Reserved